Soligenix, Inc.(SNGX)Earnings, Financials & Key RatiosSoligenix, Inc. (SNGX) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to generate commercial revenue combined with a dwindling cash balance of $6.0 million as of 2026Q1 presents an unacceptable risk of near-term dilutive financing for shareholders.
Soligenix, Inc. (SNGX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Soligenix, Inc. (SNGX) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $0.28vs $0.30+6.7% | — |
| Q2 2026 | Apr 3, 2026 | $0.32vs $0.27+218.5% | — |
| Q4 2025 | Nov 7, 2025 | $0.58vs $0.63+7.9% | — |
| Q3 2025 | Aug 14, 2025 | $0.82vs $0.79-3.8% | — |
Recent stock market news and headlines for Soligenix, Inc. (SNGX)
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.com, a leading investment platform for retail investors
Key metrics vs top competitors for Soligenix, Inc. (SNGX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.39 | $3.98M | -0.18 | — | — | -235.5% | — | |
| $2.98 | $327.88K | -0.31 | — | -227.72% | -25.53% | — | |
| $6.00 | $4.32M | -0.70 | -92.58% | -9388.51% | -131.3% | — | |
| $5.67 | $1.97B | -9.45 | 698.96% | -102.06% | -44.1% | — | |
| $81.57 | $9.68B | 31.86 | 37.55% | 23.13% | 126.27% | — | |
| $3.50 | $145.75M | -1029.41 | 10.37% | 52.16% | — | — |
Soligenix, Inc. (SNGX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Soligenix, Inc. (SNGX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 28, 2026·SEC
Feb 12, 2026·SEC
Jan 23, 2026·SEC
Get notified when SNGX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Soligenix, Inc. (SNGX) stock FAQ — growth, dividends, profitability & financials explained
Soligenix, Inc. (SNGX) reported a net loss of $11.0M for fiscal year 2025.
Soligenix, Inc. (SNGX) has a return on equity (ROE) of -235.5%. Negative ROE indicates the company is unprofitable.
Soligenix, Inc. (SNGX) had negative free cash flow of $10.8M in fiscal year 2025, likely due to heavy capital investments.
